Transaction #8253 · Form 4 · 0001193125-25-281626
Perspective Therapeutics, Inc. · Purchase · Common Stock
Perspective Therapeutics, Inc. · Transacted November 12, 2025 · Filed November 14, 2025
What does this filing report?
An SEC Form 4 filing for Perspective Therapeutics, Inc. records a purchase involving Common Stock on November 12, 2025. The reported quantity was 9,498. The filing date is November 14, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0000728387
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 9,498
- Reported price
- 2.1
- Reference value
- 19,945.8
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 9,864
- Ownership description
- RFW3 Revocable Trust
- SEC acceptance time
- Nov 14, 2025, 8:00 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Williamson Robert F III ↗
Director
CIK 0001397331
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
No footnotes are available in this record.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.